Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.67 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.67 |
| ▸ | GAA | P10253 | 3/20 | 0.67 |
| ▸ | RAB9A | P51151 | 6/20 | 0.64 |
| ▸ | NPC1 | O15118 | 5/20 | 0.64 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.64 |
| ▸ | LMNA | P02545 | 1/20 | 0.64 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.64 |
| ▸ | MAPT | P10636 | 4/20 | 0.63 |
| ▸ | TP53 | P04637 | 2/20 | 0.62 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.59 |
| ▸ | POLB | P06746 | 2/20 | 0.58 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.56 |
| ▸ | TSHR | P16473 | 2/20 | 0.56 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.56 |
| ▸ | MEN1 | O00255 | 3/20 | 0.55 |
| ▸ | HPGD | P15428 | 2/20 | 0.55 |
| ▸ | METAP2 | P50579 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29603459 | 1.00 | ALDH1A1 (0.67) | ALDH1A1KDM4EGAARAB9ANPC1 | |
| SCHEMBL29603751 | 0.91 | GAA (0.70) | ALDH1A1KDM4EGAARAB9ANPC1 | |
| SCHEMBL13290719 | 0.85 | NPC1 (0.68) | ALDH1A1KDM4EGAARAB9ANPC1 | |
| SCHEMBL27739490 | 0.80 | RAB9A (0.76) | ALDH1A1KDM4EGAARAB9ANPC1 | |
| SCHEMBL22833904 | 0.80 | NPC1 (0.86) | ALDH1A1KDM4EGAARAB9ANPC1 | |
| SCHEMBL29603991 | 0.80 | NPC1 (0.86) | ALDH1A1KDM4EGAARAB9ANPC1 | |
| SCHEMBL1437649 | 0.79 | RAB9A (0.61) | ALDH1A1KDM4EGAARAB9ANPC1 | |
| SCHEMBL1534502 | 0.79 | RAB9A (0.61) | ALDH1A1KDM4EGAARAB9ANPC1 | |
| SCHEMBL8522485 | 0.78 | TSHR (0.56) | ALDH1A1KDM4EGAARAB9ANPC1 | |
| SCHEMBL28566971 | 0.78 | GAA (0.55) | ALDH1A1KDM4EGAARAB9ANPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220259243-A1 | IRON(III) AND GALLIUM(III) METAL ORGANIC POLYHEDRA, METHODS OF MAKING SAME, AND USES THEREOF | UNIV NEW YORK STATE RES FOUND (US) | 2022-08-18 | — | — | US | disclosed |
| EP-3986482-A1 | IRON(III) AND GALLIUM(III) METAL ORGANIC POLYHEDRA, METHODS OF MAKING SAME, AND USES THEREOF | The Research Foundation for The State University of New York (US) | 2022-04-27 | — | — | EP | disclosed |
| WO-2020263761-A1 | IRON(III) AND GALLIUM(III) METAL ORGANIC POLYHEDRA, METHODS OF MAKING SAME, AND USES THEREOF | THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK (US) | 2020-12-30 | — | — | WO | disclosed |
| WO-2020263761-A1 | IRON(III) AND GALLIUM(III) METAL ORGANIC POLYHEDRA, METHODS OF MAKING SAME, AND USES THEREOF | THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK (US) | 2020-12-30 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220259243-A1 | IRON(III) AND GALLIUM(III) METAL ORGANIC POLYHEDRA, METHODS OF MAKING SAME, AND USES THEREOF | SLC39A3, TFRC, SLC40A1 | ALDH1A1 4725/4885KDM4E 4323/4885GAA 1616/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.